SEC FORM 4
—
SAB Biotherapeutics, Inc. (SABS)
Disposition (code F) of 473 shares; price not stated (see filing).
Reporting Person Kropotova Alexandra · Officer Title CHIEF MEDICAL OFFICER · Transaction Code F
Traded Sep 17, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001193125-26-395552 · filed 2026-09-18 · View filing →